InvestorsObserver
×
News Home

How Does Flexion Therapeutics Inc (FLXN) Stock Rank on Wall Street Monday?

Monday, March 22, 2021 11:03 AM | InvestorsObserver Analysts

Mentioned in this article

How Does Flexion Therapeutics Inc (FLXN) Stock Rank on Wall Street Monday?

InvestorsObserver is giving Flexion Therapeutics Inc (FLXN) an Analyst Rating Rank of 74, meaning FLXN is ranked higher by analysts than 74% of stocks. The average price target for FLXN is $20.9 and analyst’s rate the stock as a Strong Buy

Overall Score - 4.8
Wall Street analysts are rating FLXN a Strong Buy today. Find out what this means to you and get the rest of the rankings on FLXN!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.

InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Flexion Therapeutics Inc Stock Today?

Flexion Therapeutics Inc (FLXN) stock is trading at $10.38 as of 10:54 AM on Monday, Mar 22, a rise of $0.19, or 1.92% from the previous closing price of $10.18. The stock has traded between $10.09 and $10.49 so far today. Volume today is 871,266 compared to average volume of 748,534.

Click Here to get the full report on Flexion Therapeutics Inc (FLXN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App